The present invention relates to compounds which acivate the p53 response, and find use in, for example, hyperproliferative diseases such as cancer treatment and potentially other diseases/conditions (involving sirtuin function).
|Publication status||Published - 13 Mar 2008|
Lain, S., Lane, D., Stark, M. J. R., McCarthy, A. R., Hollick, J. J., & Westwood, N. J. (2008). IPC No. A61K31/17. p53 activating benzoyl urea and benzoyl thiourea compounds. (Patent No. WO2008029096). http://patentscope.wipo.int/search/en/WO2008029096